APA (7th ed.) Citation

K, D., JH, K., & CS, F. (2019). Authors Reply to Letter to the Editor- In Response to: Comment on Durrani et al.'s "Adalimumab for Ocular Inflammation". Ocular immunology and inflammation, 27(1), 71. https://doi.org/10.1080/09273948.2017.1379545

Chicago Style (17th ed.) Citation

K, Durrani, Kempen JH, and Foster CS. "Authors Reply to Letter to the Editor- In Response to: Comment on Durrani Et Al.'s "Adalimumab for Ocular Inflammation"." Ocular Immunology and Inflammation 27, no. 1 (2019): 71. https://doi.org/10.1080/09273948.2017.1379545.

MLA (9th ed.) Citation

K, Durrani, et al. "Authors Reply to Letter to the Editor- In Response to: Comment on Durrani Et Al.'s "Adalimumab for Ocular Inflammation"." Ocular Immunology and Inflammation, vol. 27, no. 1, 2019, p. 71, https://doi.org/10.1080/09273948.2017.1379545.